Biologic activity of low dosage IL-2 treatment in vivo. Molecular assessment of cytokine network interaction.

作者: Florian Hladik , Herbert Tilg , Wolfgang Vogel , Udo Schwulera , Christoph Huber

DOI:

关键词: Northern blotMolecular biologyMonokineGeneMessenger RNAPeripheral blood mononuclear cellPharmacologyIn vivoBlotBiologyNeutrophilia

摘要: The sequence of activation the components cytokine network subsequent to in vivo application different dosages IL-2 is still poorly understood. Although side effects therapy are dose dependent, dose-response relationship for induction potentially beneficial or harmful genes remains be studied. We examined patterns gene expression after treatment chronic hepatitis B patients with various doses a phase 1 trial. Total RNAs were isolated from PBMC harvested at time points s.c. injection natural ranging 30,000 1,000,000 U. Dose-dependent on mRNA IL-2, GM-CSF, IFN-gamma, TNF-alpha, and IL-6 assessed using Northern blotting slot techniques. A single U nIL-2 induced selective long-lasting GM-CSF genes, which was not accompanied by accumulation TNF-alpha mRNAs. Larger monokine associated systemic effects. levels cytokines related biologic activity correlated specific proteins cellular parameters: soluble IL-2R serum lymphopenia, neutrophilia, c-reactive protein concentrations. Taken together these data indicate unexpected immunoregulatory activities very low nontoxic vivo.

参考文章(28)
J W Mier, F R Aronson, R P Numerof, IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells. Journal of Immunology. ,vol. 141, pp. 4250- 4257 ,(1988)
J J Oppenheim, T Kasahara, S F Dougherty, J J Hooks, Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. Journal of Immunology. ,vol. 130, pp. 1784- 1789 ,(1983)
Howard S. Jaffe, Michael A. Palladino, Anthony A. Rayner, Terje P. Espevik, Brett T. Gemlo, Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells. Cancer Research. ,vol. 48, pp. 5864- 5867 ,(1988)
Herbert Tilg, Wolfgang Vogel, Jeanie Tratkiewicz, Walter Ernst Aulitzky, Manfred Herold, Michael Gruber, Dietmar Geissler, Florian Umlauft, Gert Judmaier, Ulrich Schwulera, Alexander Thrun, Christian Huber, Pilot study of natural human interleukin-2 in patients with chronic hepatitis B Journal of Hepatology. ,vol. 19, pp. 259- 267 ,(1993) , 10.1016/S0168-8278(05)80580-X
A Kasid, EP Director, SA Rosenberg, Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients. Journal of Immunology. ,vol. 143, pp. 736- 739 ,(1989)
C. A. Y. Seipp, M. C. Custer, S. E. Ettinghausen, S. O. Sharrow, S. A. Rosenberg, A. A. Rayner, M. T. Lotze, Y. L. Matory, In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. Journal of Immunology. ,vol. 135, pp. 2865- 2875 ,(1985)
Michael A Caligiuri, Christine Murray, Robert J Soiffer, Thomas R Klumpp, Michael Seiden, Keith Cochran, Christine Cameron, Christopher Ish, Lynn Buchanan, Denise Perillo, None, Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity. Journal of Clinical Oncology. ,vol. 9, pp. 2110- 2119 ,(1991) , 10.1200/JCO.1991.9.12.2110
Gordon G Wong, JoAnn S Witek, Patricia A Temple, Kathleen M Wilkens, Anne C Leary, Deborah P Luxenberg, Simon S Jones, Eugene L Brown, Robert M Kay, Elizabeth C Orr, Charles Shoemaker, David W Golde, Randal J Kaufman, Rodney M Hewick, Elizabeth A Wang, Steven C Clark, Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins Science. ,vol. 228, pp. 810- 815 ,(1985) , 10.1126/SCIENCE.3923623
Toshio Hirano, Kiyoshi Yasukawa, Hisashi Harada, Tetsuya Taga, Yasuo Watanabe, Tadashi Matsuda, Shin-ichiro Kashiwamura, Koichi Nakajima, Koichi Koyama, Akihiro Iwamatsu, Susumu Tsunasawa, Fumio Sakiyama, Hiroshi Matsui, Yoshiyuki Takahara, Tadatsugu Taniguchi, Tadamitsu Kishimoto, Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin Nature. ,vol. 324, pp. 73- 76 ,(1986) , 10.1038/324073A0